|By PR Newswire||
|April 11, 2014 09:53 AM EDT||
OXFORD, England, April 11, 2014 /PRNewswire/ --
PharmaVentures is pleased to announce that it has been appointed by Novartis as advisors on the future options for its UK Horsham site. These options could include reusing part of the site as a science or business park, thereby creating a legacy with the possibility of creating some highly skilled jobs for the area in the future. PharmaVentures will provide expert advice on the feasibility of doing this, and to help identify potential partners.
See the Novartis press release here.
Dr Fintan Walton, Chief Executive, PharmaVentures, said "The Novartis Horsham site is a perfect location for a high technology park. Novartis has built state of the art facilities, suitable for pharmaceutical / life science or other high technology businesses. With such high quality facilities, we expect interest from both universities and research institutes." Dr Walton added "The site would also be ideal as a business park as Horsham is an attractive location due to its strong international links through Gatwick airport and its proximity to London."
PharmaVentures is a premier transaction advisory firm and a leader in partnering, M&A deals and strategic alliances. Their unrivalled bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes them uniquely placed to support businesses in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success in transactions.
Find out more http://www.pharmaventures.com
Our services include:
• M&A (divestments, mergers, acquisitions and strategic transactions)
• Strategy (commercialisation, deal strategy, due diligence, market entry)
• Valuation and Positioning (licensing, M&A, fund raising & expert testimonies)
• Licensing (in and out licensing)
• Expert Testimony (patent infringement, deal disagreements, taxation, determining damages)
Now in its 23rd year, PharmaVentures is based in Oxford, UK, with offices in London and San Francisco.
For further information, contact:
Dr Fintan Walton
So, you bought into the current machine learning craze and went on to collect millions/billions of records from this promising new data source. Now, what do you do with them? Too often, the abundance of data quickly turns into an abundance of problems. How do you extract that "magic essence" from your data without falling into the common pitfalls? In her session at @ThingsExpo, Natalia Ponomareva, Software Engineer at Google, provided tips on how to be successful in large scale machine learning...
Oct. 1, 2016 08:30 AM EDT Reads: 2,497
Cognitive Computing is becoming the foundation for a new generation of solutions that have the potential to transform business. Unlike traditional approaches to building solutions, a cognitive computing approach allows the data to help determine the way applications are designed. This contrasts with conventional software development that begins with defining logic based on the current way a business operates. In her session at 18th Cloud Expo, Judith S. Hurwitz, President and CEO of Hurwitz & ...
Oct. 1, 2016 08:30 AM EDT Reads: 3,400
Oct. 1, 2016 08:00 AM EDT Reads: 1,309
Oct. 1, 2016 08:00 AM EDT Reads: 2,253
Oct. 1, 2016 07:30 AM EDT Reads: 1,173
Oct. 1, 2016 07:00 AM EDT Reads: 2,405
Oct. 1, 2016 07:00 AM EDT Reads: 1,865
Oct. 1, 2016 06:30 AM EDT Reads: 1,931
Oct. 1, 2016 06:15 AM EDT Reads: 811
Oct. 1, 2016 06:00 AM EDT Reads: 1,946
Oct. 1, 2016 06:00 AM EDT Reads: 2,807
Oct. 1, 2016 05:45 AM EDT Reads: 1,344
Oct. 1, 2016 05:30 AM EDT Reads: 644
Oct. 1, 2016 05:15 AM EDT Reads: 1,438
Oct. 1, 2016 05:00 AM EDT Reads: 4,759